Insider Sale: Director at $ABM Sells 3,711 Shares

Thomas M Gartland, a $ABM director, sold 3,711 shares on 06-13-2025 for approximately $168,906, representing 10.7% of their holdings. This sale is part of a broader trend of insider selling at $ABM over the past six months, with executives like the CEO and other EVPs also divesting shares. In Q1 2025, institutional investors showed mixed sentiment, with ALLIANCEBERNSTEIN L.P. and BLACKROCK, INC. decreasing their positions, while BOSTON PARTNERS and LSV ASSET MANAGEMENT increased theirs; UBS issued a "Buy" rating on 06/09/2025.

Analysis

A director at ABM Industries ($ABM), Thomas M Gartland, executed a sale of 3,711 shares on June 13, 2025, for an estimated $168,906, reducing his holdings in this class of stock by approximately 10.7% to 30,958 shares. This transaction is part of a consistent pattern of insider selling at $ABM, where insiders have conducted 10 sales and zero purchases in the open market over the past six months. Notably, President and CEO Scott B Salmirs sold 50,000 shares for approximately $2.61 million, EVP Sean Michael Mahoney sold 15,000 shares for around $757,000, EVP Rene Jacobsen divested 10,000 shares for about $528,000, and SVP Dean A Chin sold 4,281 shares for an estimated $224,136. Institutional activity in Q1 2025 presented a mixed picture, with 139 institutional investors adding $ABM shares to their portfolios while 163 decreased their positions. Significant sales included ALLIANCEBERNSTEIN L.P. reducing its holding by 665,721 shares (-26.0%), BLACKROCK, INC. by 469,957 shares (-4.7%), and GOLDMAN SACHS GROUP INC by 372,156 shares (-60.0%). Conversely, substantial new or increased positions were taken by BOSTON PARTNERS, which added 612,586 shares (+2129.6%), LSV ASSET MANAGEMENT, adding 553,225 shares (+66.4%), AMERICAN CENTURY COMPANIES INC, adding 406,802 shares (+34.4%), and NUVEEN ASSET MANAGEMENT, LLC, which added 334,295 shares (+99.2%) in Q4 2024. Despite the insider sales and a moderately negative sentiment score of -0.5 for $ABM, UBS issued a "Buy" rating on June 9, 2025, and no sell ratings have been reported from Wall Street analysts recently.

Key Decisions for Investors

• Investors should closely monitor the consistent pattern of insider sales at $ABM, including the recent 10.7% divestment by director Thomas M Gartland, as this could signal caution from management despite a recent 'Buy' rating from UBS.
• The divergent institutional flows, with significant new stakes from entities like Boston Partners and LSV Asset Management contrasting with large divestitures by AllianceBernstein, BlackRock, and Goldman Sachs, warrant further due diligence to understand the varying conviction levels among large investors.
• Given the mixed signals of persistent insider selling, contrasting institutional activity, and a singular analyst 'Buy' rating, scrutinizing upcoming Form 13F filings for Q2 2025 and any further insider transaction reports will be critical to assess evolving sentiment and potential catalysts for $ABM.